Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
- Status
- COMPLETED
- Phase
- PHASE2
Title XELOX FOR SALIVARY GLAND CANCERS
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE2
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
- Status
- COMPLETED
- Phase
- PHASE2
NGR-TNF in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Amifostine For SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine For Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)
- Status
- COMPLETED
- Phase
- PHASE3
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1